Cover Image

Huashi baidu granule in the treatment of pediatric patients with mild coronavirus disease 2019: A single-center, open-label, parallel-group randomized controlled clinical trial

Background: Since late February 2022, a wave of coronavirus disease 2019 (COVID-19) mainly caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Omicron variant rapidly appeared in Shanghai, China. Traditional Chinese medicine treatment is recommended for pediatric patients; how...

Full description

Saved in:

Bibliographic Details
Main Authors:	Jiande Chen (Author), Qiuyu Tang (Author), Baoqin Zhang (Author), Shuhua Yuan (Author), Jia Chen (Author), Shiyu Shen (Author), Dong Wang (Author), Jilei Lin (Author), Hongliang Dong (Author), Yong Yin (Author), Jian Gao (Author)
Format:	Book
Published:	Frontiers Media S.A., 2023-01-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Protective effect of Huashi Baidu formula against AKI and active ingredients that target SphK1 and PAI-1
by: Yute Zhong, et al.
Published: (2024)

Yishen Huashi Granules Ameliorated the Development of Diabetic Nephropathy by Reducing the Damage of Glomerular Filtration Barrier
by: Tingting Zhao, et al.
Published: (2022)

Qingchang Huashi granule ameliorates experimental colitis via restoring the dendritic cell-mediated Th17/Treg balance
by: Jia Jia, et al.
Published: (2020)

Modulating effect of Xuanfei Baidu granule on host metabolism and gut microbiome in rats
by: Qiaoyu He, et al.
Published: (2022)

Effectiveness and safety analysis of SanHanHuaShi granules for the treatment of coronavirus disease 2019: Study protocol and statistical analysis plan for a randomized, parallel-controlled, open-label clinical trial
by: Yangyang Liu, et al.
Published: (2022)

An exploratory, open-label, randomized, multicenter trial of hachimijiogan for mild Alzheimer's disease
by: Mosaburo Kainuma, et al.
Published: (2022)

Pharmacokinetic interactions and tolerability of berberine chloride with simvastatin and fenofibrate: an open-label, randomized, parallel study in healthy Chinese subjects
by: Li G, et al.
Published: (2018)

Use of Baidu Index to Track Chinese Online Behavior and Interest in Kidney Stones
by: Wang T, et al.
Published: (2020)

Efficacy of polyethylene glycol loxenatide versus insulin glargine on glycemic control in patients with type 2 diabetes: a randomized, open-label, parallel-group trial
by: Shuo Zhang, et al.
Published: (2023)

An open-label, parallel-group, randomized clinical trial of different silver diamine fluoride application intervals to arrest dental caries
by: Robert J. Schroth, et al.
Published: (2024)

Effect of food on the pharmacokinetics of zoliflodacin granules for oral suspension: Phase I open‐label randomized cross‐over study in healthy subjects
by: Alison Luckey, et al.
Published: (2023)

Correction: An open‑label, parallel‑group, randomized clinical trial of different silver diamine fluoride application intervals to arrest dental caries
by: Robert J. Schroth, et al.
Published: (2024)

Comparison of effectiveness and safety of immunotherapy of warts with intralesional versus subcutaneous MMR vaccine: An open label randomized, parallel group, clinical trial
by: Abanti Saha, et al.
Published: (2022)

MASSIVE, OPEN, ONLINE: LEARNING PARALLEL OR TOGETHER?
by: Ivan Yu. Travkin
Published: (2016)

Prevention of Cyclophosphamide-Induced Immunosuppression in Mice With Traditional Chinese Medicine Xuanfei Baidu Decoction
by: Huimin Yan, et al.
Published: (2021)

Spatiotemporal distribution of migraine in China: analyses based on baidu index
by: Liling Lin, et al.
Published: (2023)

An open-label study on the short-term effects of a novel EFSA-compliant nutraceutical combination in mild-to-moderate hypercholesterolemia
by: Piercarlo Minoretti, et al.
Published: (2022)

The Impact of a Mobile Support Group on Distress and Physical Activity in Breast Cancer Survivors: Randomized, Parallel-Group, Open-Label, Controlled Trial
by: Miyeon Jung, et al.
Published: (2023)

Mechanism of the anti-influenza functions of Baidu San based on network pharmacology and molecular docking
by: Wei Ling, et al.
Published: (2024)

Jin-Zhen oral liquid for pediatric coronavirus disease (COVID-19): A randomly controlled, open-label, and non-inferiority trial at multiple clinical centers
by: Qian Dong, et al.
Published: (2023)

Corrigendum: Prevention of Cyclophosphamide-Induced Immunosuppression in Mice With Traditional Chinese Medicine Xuanfei Baidu Decoction
by: Huimin Yan, et al.
Published: (2022)

Ashwagandha (Withania somnifera) and Shunthi (Zingiber officinale) in mild and moderate COVID-19: An open-label randomized controlled exploratory trial
by: Harbans Singh, et al.
Published: (2023)

Head-to-head comparison of tazarotene and calcitriol with or without sequential therapy in mild-to-moderate psoriasis: A randomized open-label study
by: Jaspreet Kaur Sidhu, et al.
Published: (2023)

AYUSH-64 as an adjunct to standard care in mild to moderate COVID-19: An open-label randomized controlled trial in Chandigarh, India
by: Harbans Singh, et al.
Published: (2022)

Evaluation of the Liver Disease Information in Baidu Encyclopedia and Wikipedia: Longitudinal Study
by: Sun, Fei, et al.
Published: (2021)

Baidu Index and COVID-19 Epidemic Forecast: Evidence From China
by: Jianchun Fang, et al.
Published: (2021)

Safety and efficacy of the swift microwave device in patients with mild‐to‐moderate onychomycosis: Protocol of an open‐label, randomized, dose‐finding pilot study
by: Aditya K. Gupta, et al.
Published: (2024)

Efficacy of terbinafine and itraconazole in different doses and in combination in the treatment of tinea infection: A randomized controlled parallel group open labeled trial with clinico-mycological correlation
by: Satyendra K Singh, et al.
Published: (2020)

Jingqianshu granules mitigates premenstrual depression by regulating orexin signaling
by: Ping Dong, et al.
Published: (2024)

Using the Baidu index to predict trends in the incidence of tuberculosis in Jiangsu Province, China
by: Yue Wang, et al.
Published: (2023)

Deep learning models for hepatitis E incidence prediction leveraging Baidu index
by: Yanhui Guo, et al.
Published: (2024)

Implant impression accuracy of parallel and non-parallel implants: a comparative in-vitro analysis of open and closed tray techniques
by: Motaz S. Osman, et al.
Published: (2019)

Asthma prevalence based on the Baidu index and China's Health Statistical Yearbook from 2011 to 2020 in China
by: Yahui Li, et al.
Published: (2023)

Self-Assessed Benefits of a Prostate Health Formulation on Nocturia in Healthy Males With Mild Lower Urinary Tract Symptoms: An Open Label Study
by: Steven P Hirsh DPM, et al.
Published: (2020)

Lavender (Lavandula angustifolia) syrup as an adjunct to standard care in patients with mild to moderate COVID-19: An open-label, randomized, controlled clinical trial
by: Marzieh Gharaaty, et al.
Published: (2023)

The effect of azoximer bromide (Polyoxidonium®) in patients hospitalized with coronavirus disease (COVID-19): an open-label, multicentre, interventional clinical study
by: Sergey V Efimov, et al.
Published: (2021)

Evaluation of Medical Information on Male Sexual Dysfunction on Baidu Encyclopedia and Wikipedia: Comparative Study
by: Ming Ma, et al.
Published: (2022)

Analysis of the situations and influencing factors of public anxiety in China: based on Baidu index data
by: Tiantian Xie, et al.
Published: (2024)

Using Baidu Index Data to Improve Chickenpox Surveillance in Yunnan, China: Infodemiology Study
by: Zhaohan Wang, et al.
Published: (2023)

Atomoxetine Open-Label Trial in ADHD
by: J Gordon Millichap
Published: (2002)